Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

It's downright silly agreed Bjdev89...but life for burgeoning biomed plays with Canadian based HQ's unless and until growth driving catalysts start to occur which the street will finally begin rewarding them for.

Their 1st approved ANDA for example hasn't yet been able to drive the expected revenues it should be due to other companies stalling all the strengths IPCI's partner PAR's been able to launch commercialization on.

And the ongoing FDA delays on their next pending ANDA's which are long overdue hasn't helped convince the street of anything either.

And the mystery/intrigue surrounding their latest tech platform additions podras and npodds which they've recently implemented into Regabatin has continued to cause the street to take a wait and see approach unless and until clinical phase III trials and possible partnerships are announced.

Basically it all adds up to bargain entry prices continuing to be available for any retailers who do stumble across IPCI and have the stomach for playing Canadian based biomed plays Wall Street hasn't begun to reward yet right cheers!